Showing posts from tagged with: genetic counseling

The Power of Genetic Counseling at Pathway Genomics

Posted on 10/13/2014 in Blog Post

SAN DIEGO, CA - OCTOBER 13, 2014 - What is a genetic counselor and what does a genetic counselor do at Pathway Genomics? From the outside you would think that answering this question would be a simple task for someone who has spent more than 20 years providing clinical genetic counseling in a wide variety of circumstances such as prenatal, neurogenetics, hematology, and cancer genetics. Genetic counselors are a fiercely protective and private lot when it comes to our clients and our profession. Who we are and what we do are intimately intertwined.  

Using Genetic Information for Healthy Lifestyle Management

Posted on 10/02/2014 in Blog Post

medcan graphic
SAN DIEGO, CAOctober 2. 2014 – Genetic testing provides the opportunity to gain all sorts of insight--from the potential to diagnose rare diseases, to providing targeted therapies, to prevention. Although we have historically focused on the use of genetic testing for diagnosis, less attention has been given to genetic testing’s clinical use in preventing disease and managing health. In the US, only 2% of the population has ever undergone genetic testing. However many studies show that the majority of patients and physicians believe that genetic testing is on the rise and that a significantly higher portion of the population could benefit from genetic testing to help identify risk for and even diagnose preventable conditions.  

Pathway Genomics Announces Commitment to Free the Data Movement at NSGC Conference

Posted on 09/18/2014 in News, Press Releases

SAN DIEGO, CASeptember 18, 2014 – Pathway Genomics Corporation, a global clinical genetic testing company, announced today at the National Society of Genetic Counselors’ 33rd Annual Education Conference its commitment to Free the Data, a movement dedicated to open access to genetic data and collaboration through information sharing.  

Pathway Genomics Launches BreastTrue NGS High Risk Breast Cancer Panel with PALB2

Posted on 09/10/2014 in News, Press Releases

SAN DIEGO, CASeptember 10. 2014 – Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, today announced it has launched BreastTrueTM High Risk Panel, a next-generation sequencing test with deletion/duplication analysis to detect mutations in seven high-risk breast cancer susceptibility genes, including BRCA1, BRCA2 and PALB2.